Literature DB >> 16870528

Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults.

Zelalem Temesgen1, Francesca Cainelli, Eric M Poeschla, Stacey A R Vlahakis, Sandro Vento.   

Abstract

Despite dramatic declines in HIV-associated morbidity and mortality as a result of highly active antiretroviral therapy, management of heavily treatment-experienced patients remains complex and challenging. Treatment response rates with subsequent antiretroviral regimens are lower than with initial antiretroviral therapy. Additionally, increased mortality has been associated with multidrug-resistant HIV. We review data relevant to management of such patients and offer a systematic approach to constructing a salvage antiretroviral regimen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870528     DOI: 10.1016/S1473-3099(06)70550-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  11 in total

Review 1.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 2.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

3.  Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease.

Authors:  Ahmed M Bayoumi; Paul G Barnett; Vilija R Joyce; Susan C Griffin; Huiying Sun; Nick J Bansback; Mark Holodniy; Gillian Sanders; Sheldon T Brown; Tassos C Kyriakides; Brian Angus; D William Cameron; Aslam H Anis; Mark Sculpher; Douglas K Owens
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

Review 4.  Virus maturation as a new HIV-1 therapeutic target.

Authors:  Catherine S Adamson; Karl Salzwedel; Eric O Freed
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

Review 5.  Tipranavir: a review of its use in the management of HIV infection.

Authors:  Jennifer S Orman; Caroline M Perry
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Current and future antiretroviral treatment options in paediatric HIV infection.

Authors:  Carlo Giaquinto; Erika Morelli; Federica Fregonese; Osvalda Rampon; Martina Penazzato; Anita de Rossi; Ruggero D'Elia
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

7.  Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

Authors:  Brett D Shepard; Mona R Loutfy; Janet Raboud; Frank Mandy; Colin M Kovacs; Christina Diong; Michele Bergeron; Victoria Govan; Stacey A Rizza; Jonathan B Angel; Andrew D Badley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

8.  Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.

Authors:  Matthias Mehling; Henning Drechsler; Jens Kuhle; Martin Hardmeier; Ruediger Doerries; Stephan Ruegg; Achim Gass
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

9.  Two cases of multidrug-resistant human immunodeficiency virus infection treated with atazanavir and lopinavir/ritonavir combination therapy.

Authors:  Heekyoung Choi; Su Jin Jeong; Han Sung Lee; Bum Sik Chin; Suk Hoon Choi; Sang Hoon Han; Myung Soo Kim; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

10.  Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.

Authors:  Marie Ballif; Bruno Ledergerber; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Milos Opravil; Rainer Weber
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.